Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pericoital levonorgestrel contraception for women with infrequent intercourse
ACTRN12611001037998Phase 3Not yet recruiting
- Sponsor
- World Health Organization
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, open-label, single-arm trial of avatrombopag in contraception, sponsored by World Health Organization. Primary endpoints: Pregnancy, Safety and 1 more. Planned start Nov 2011; status: not yet recruiting.
02
Drugs
avatrombopag
03
Conditions
contraception
Beyond the preview
Go deeper on ACTRN12611001037998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001037998.